Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread
globally, it became evident that the SARS-CoV-2 virus infects multiple organs including the …

Neither the disease mechanism nor treatments for COVID-19 are currently known. Here, we
present a novel molecular mechanism for COVID-19 that provides therapeutic intervention …

Hereditary angioedema (HAE), a rare but life-threatening condition, manifests as acute
attacks of facial, laryngeal, genital, or peripheral swelling or abdominal pain secondary to …

In times of coronavirus disease 2019 (COVID-19), the impact of severe acute respiratory
syndrome (SARS)-coronavirus (CoV)-2 infection on pregnancy is still unclear. The presence …

There is a current need to develop methods for the sensitive detection of peptide biomarkers
in complex mixtures of molecules, such as biofluids, to enable early disease detection …

A growing body of clinical evidence shows that vascular leakage leads to pulmonary edema
in coronavirus disease 2019 (COVID-19) patients. Coronaviruses including severe acute …

Angio-oedema is a rare but potentially life threatening side-effect of angiotensin-converting-
enzyme (ACE) inhibitor treatment. Identification of individuals at risk of this adverse effect is …

Angiotensin-converting enzyme (ACE, kininase II) inhibitors reduce mortality in patients who
have hypertension, congestive heart failure, and diabetic nephropathy and in patients who …

Angioedema is a potentially life-threatening adverse effect of angiotensin-converting
enzyme inhibitors. Bradykinin and substance P, substrates of angiotensin-converting …